Aside from 5‐FU treatments, studies have shown that 15% of GCa patients are HER2‐positive,12, 13 and these patients can be treated with a HER2 inhibitor as an alternative treatment once 5‐FU treatment has failed. This evidence concerns the gene ERBB2 and temporal arteritis.